Ascentage Pharma Group International (AAPG) Other Accumulated Expenses: 2023-2024
Historic Other Accumulated Expenses for Ascentage Pharma Group International (AAPG) over the last 2 years, with Dec 2024 value amounting to $35.4 million.
- Ascentage Pharma Group International's Other Accumulated Expenses was N/A to $34.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $34.5 million, marking a year-over-year change of. This contributed to the annual value of $35.4 million for FY2024, which is 82.91% down from last year.
- Latest data reveals that Ascentage Pharma Group International reported Other Accumulated Expenses of $35.4 million as of FY2024, which was down 82.91% from $206.9 million recorded in FY2023.
- Ascentage Pharma Group International's Other Accumulated Expenses' 5-year high stood at $206.9 million during FY2023, with a 5-year trough of $35.4 million in FY2024.
- In the last 2 years, Ascentage Pharma Group International's Other Accumulated Expenses had a median value of $121.1 million in 2023 and averaged $121.1 million.
- Data for Ascentage Pharma Group International's Other Accumulated Expenses shows a maximum YoY crashed of 82.91% (in 2024) over the last 5 years.
- Over the past 2 years, Ascentage Pharma Group International's Other Accumulated Expenses (Yearly) stood at $206.9 million in 2023, then tumbled by 82.91% to $35.4 million in 2024.